RenovoRx Inc. (RNXT) Stock Surges Following U.S. FDA Approval for RenovoCath Delivery System
RenovoRx Inc. (RNXT) stock prices surged by 19.14% some time after market trading commenced on September 7th 2021. This brought the price per share up to USD$9.43 early on in the trading day. RenovoCath Delivery System Approval September 7th 2021 saw RNXT stock announce having received a new 510(k) clearance for its proprietary RenovoCath Delivery […]